Publication date: Feb 01, 2025

The COVID-19 pandemic ushered widespread adoption of telehealth (TH) by cystic fibrosis (CF) centers in the USA. TH was initially described as well-accepted by both clinicians and patients. As we move past the unusual circumstances of the pandemic, the sustainability of TH remains untested. This study sought to test the durability of clinician perceptions of TH post-pandemic. This is a cross-sectional, survey study of clinicians at seven US CF centers. We refined a previously disseminated survey initially designed to assess clinician perceptions of TH in 2020. Survey results were analyzed using descriptive statistics and current responses were compared to prior results. Clinician perceptions surrounding TH remain high but have changed over time with 75% now endorsing satisfaction (90% in 2020, p = 0. 02). The most cited barriers were technology limitations (68%) and limited in-person assessments (66%). We found a significant decrease in concern over missing in-person assessments compared to 2020. Benefits of TH included convenience for patients and families (100%) and reduction in missed days of school or work (100%). In total, 83% of current respondents felt TH should remain part of routine CF care. A majority indicated certain patient characteristics increased their preference to conduct at least one TH visit per year. Despite restoration of full access to in-person care, clinicians caring for pwCF continue to use TH across the surveyed CF centers post-pandemic. Respondents continue to view TH favorably. Further study is needed to understand for which patient and clinical scenarios TH is most appropriate.

Semantics

Original Article